bioRxivGenomicsPreprint
Sequencing and de novo assembly reveals genomic variations associated with differential responses of Candida albicans ATCC 10231 towards fluconazole, pH and non-invasive growth
Gajanan B. ZoreiD, Archana D. Thakre, Rajendra PatiliD, Chaithra Pradeep, Bipin BalaniD
Abstract
The whole genome sequencing generated 8.09 million paired-end reads, which were assembled into 2,262 scaffolds totaling 17,113,050 bp in length. We predict 7,654 coding regions and 7,647 genes, and annotated the coding regions with gene ontology terms based on similarity to other annotated genomes. Genome comparisons revealed variations (including SNP and indels in genes involved in pH response, fluconazole resistance and invasive growth) compared to C. albicans SC5314 and WO1.
- organism: yeast
- assay: whole-genome sequencing
- research focus: genome assembly
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Polygenetic Determinants of Azole Resistance, Tolerance, and Heteroresistance in Candida albicans
Kyle Schutz, Cécile Gautier, … Iuliana V. Ene·bioRxiv·Jun 29, 2025
- Selection of Ethanol Tolerant Strains of Candida albicans by Repeated Ethanol Exposure Results in Strains with Reduced Susceptibility to Fluconazole
A. Day, C. A. Kumamoto·bioRxiv·Sep 13, 2023
- Antifungal tolerance and resistance emerge at distinct drug concentrations and rely upon different aneuploid chromosomes
F. Yang, E. F. Scopel, … J. Berman·bioRxiv·Nov 30, 2022
- Candida albicans genetic background influences mean and heterogeneity of drug responses and genome stability during evolution to fluconazole
A. C. Gerstein, J. Berman·bioRxiv·Feb 27, 2020
- Aneuploidy, polyploidy, and loss of heterozygosity distinguish serial bloodstream isolates of Candida albicans
Nancy E. Scott, Xin Zhou, … Anna M. Selmecki·Microbial GenomicsPeer-reviewed·Feb 26, 2026
- Thirty years of fluconazole therapy selects an azole-resistant Candida albicans isolate with a pre-adapted physiological, metabolic and structural state
Claudia Marcela Parra‐Giraldo, Julio Jesús Estrada‐Valbuena, … Lucía Monteoliva·bioRxiv·Sep 21, 2026